Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Predictors of Antidepressant Response [Phase 4]
A Phase 4 clinical trial from the University of Michigan investigated predictors of antidepressant response in depression. The study has com…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) [NA]
A completed clinical trial evaluated Low Field Magnetic Stimulation for treatment-resistant depression, with results posted in 2017.
-
CLINICAL_TRIALS other · 2017-12-05Clinical Trial Update: Brain Function in Depression and Insulin Resistance [NA]
This clinical trial update reports that a University of Pittsburgh study on brain function in depression and insulin resistance has been ter…
-
FDA approval · 2017-12-04FDA Approved: ARIPIPRAZOLE — Original Application (Solco Healthcare U.S., LLC)
FDA approved ARIPIPRAZOLE from Solco Healthcare U.S., LLC as an original generic application. The approval allows generic aripiprazole for t…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety [NA]
A completed pilot trial assessing a mobile health tool for patients with anxiety and depression; results were posted in December 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Effectiveness of Exercise in the Treatment of Depression [NA]
A clinical trial is investigating the effectiveness of exercise as a treatment for depression in primary care. The study (NCT03358433) is sp…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Evaluation of an Integrated Microfinance and Depression Care Program for Women [NA]
A completed clinical trial evaluating an integrated microfinance and depression care program for women; outcomes are not reported in the pro…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Familiy Medicine Perspective to Maternal-infant Bonding
A completed clinical trial, updated on ClinicalTrials.gov, evaluating maternal-infant bonding from a family medicine perspective. It address…
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Effects of Mindfulness Based Cognitive Therapy on Emotional Processing [NA]
Clinical trial update evaluating the effects of Mindfulness Based Cognitive Therapy on emotional processing in individuals with unipolar dep…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic quetiapine under an Original Application (ANDA204253), making a generic version of q…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
FDA approved a generic quetiapine fumarate product from Accord Healthcare Inc. under an original ANDA.
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' quetiapine fumarate under an Original Application, making a generic version of the antipsychotic avail…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Transcranial Laser Therapy for Major Depressive Disorder [NA]
This clinical trial update reports the completion of a study evaluating transcranial laser therapy for major depressive disorder. Results we…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic quetiapine fumarate product from Aurobindo Pharma Limited. Quetiapine is used to treat s…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE EXTENDED RELEASE — Original Application (ACI Healthcare USA, Inc.)
FDA approved an original application for quetiapine extended-release (generic) by ACI Healthcare USA, Inc., making a generic version of quet…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Decreasing Youth Involvement in Violence in Burundi [NA]
This update notes the completed University of Konstanz clinical trial in Burundi aimed at reducing youth involvement in violence among indiv…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Task Sharing for the Care of Severe Mental Disorders in a Low-income Country [Phase 3]
A Phase 3 trial evaluating a task-sharing care model for schizophrenia, bipolar disorder, major depressive disorder, and schizoaffective dis…
-
CLINICAL_TRIALS withdrawal · 2017-11-29Clinical Trial Update: The Antidepressant Efficacy of Low Frequency rTMS as add-on [NA]
The clinical trial evaluating low-frequency rTMS as an add-on treatment for depression has been withdrawn from clinicaltrials.gov.
-
CLINICAL_TRIALS other · 2017-11-24Clinical Trial Update: Psychosocial Group Interventions for Depression [NA]
This clinical trial update notes that a study on psychosocial group interventions for depression conducted by the University of Eastern Finl…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder [Phase 1]
A Phase 1 safety and pharmacodynamic study of ABT-436 in Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Imaging Dopamine Release in Depression [Phase 4]
Phase 4 clinical trial updating imaging dopamine release in major depressive disorder; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Metacognitive Training Program With Depression
A clinical trial evaluating a metacognitive training program for depression has been terminated.
-
FDA approval · 2017-11-20FDA Approved: FLUOXETINE — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approved NIVAGEN Pharmaceuticals' original application for fluoxetine hydrochloride, granting marketing approval for a generic version o…
-
CLINICAL_TRIALS withdrawal · 2017-11-20Clinical Trial Update: Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression. [NA]
The clinical trial evaluating Magnetic Seizure Therapy for treatment-resistant depression has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder [Phase 2]
Phase 2 study evaluating the effects of the antidepressant GSK561679 in females with major depressive disorder; results were posted in 2017.